Literature DB >> 3002438

Isolation and characterization of the human cellular myc gene product.

P Beimling, T Benter, T Sander, K Moelling.   

Abstract

Antibodies against the product of the human cellular myc gene (c-myc) were prepared against a bacterially expressed human c-myc protein by inserting the ClaI/BclI fragment of the human c-myc DNA clone in an expression vector derived from pPLc24. These antibodies cross-react with viral-coded myc (v-myc) proteins from MC29 and OK10 viruses. Furthermore, IgGs specific for synthetic peptides, corresponding to the 12 carboxy-terminal amino acids of the human c-myc gene and 16 internal amino acids, were isolated. By use of the various myc-specific antisera or IgGs, a protein of Mr 64 000 was detected in several human tumor cell lines including Colo320, small cell cancer of the lung (417d), HL60, Raji, and HeLa. This protein is larger than the corresponding v-myc or chicken c-myc proteins from avian virus transformed cells or avian bursa lymphoma cells (RP9), both of which are proteins of Mr 55 000. The human c-myc protein is located in the nucleus of Colo320 cells, exhibits a half-life of about 15 min, and is expressed at significantly lower levels than the viral protein. The human c-myc protein was enriched about 3000-fold from Colo320 cells using c-myc-specific IgG coupled to Sepharose beads. The protein binds to double-stranded DNA in vitro, a reaction that can be inhibited to more than 90% by c-myc specific IgG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002438     DOI: 10.1021/bi00344a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Identification of the human c-myc protein nuclear translocation signal.

Authors:  C V Dang; W M Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.

Authors:  R V Giles; D G Spiller; J Grzybowski; R E Clark; P Nicklin; D M Tidd
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  DNA-binding domain of human c-Myc produced in Escherichia coli.

Authors:  C V Dang; H van Dam; M Buckmire; W M Lee
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

4.  Expression of neurotensin messenger RNA in a human carcinoid tumor.

Authors:  B M Evers; J Ishizuka; C M Townsend; S Rajaraman; J C Thompson
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

5.  Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

Authors:  E L Wickstrom; T A Bacon; A Gonzalez; D L Freeman; G H Lyman; E Wickstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity.

Authors:  J Sarid; T D Halazonetis; W Murphy; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

8.  Rapid phosphorylation of the L-myc protein induced by phorbol ester tumor promoters and serum.

Authors:  K Saksela; T P Mäkelä; G Evan; K Alitalo
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.